Leaflet: information for the user
Dexamethasone Novamis 1 mg tablets EFG
Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the leaflet
Dexamethasone is a synthetic glucocorticoid (adrenocortical hormone) derived from cortisone, which regulates many of the body's metabolic processes.
Dexamethasone is used to treat:
Dexamethasone is used to treat coronavirus disease 2019 (COVID-19) in adult and adolescent patients (from 12 years of age with a body weight of at least 40 kg) with difficulty breathing and who require oxygen therapy.
Do not takeDexamethasoneNovamis
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine.
Depending on the dose and duration of treatment, glucocorticoid-induced adrenocortical insufficiency may persist for months and in individual cases up to one year after treatment is discontinued. Acute adrenocortical insufficiency induced by therapy can be minimized by a slow reduction of the dose if withdrawal is planned.
Treatment with this medicine may increase the risk of infections, and diagnosis of the same may be more difficult. Latent infections (infections that do not show symptoms) such as tuberculosis or hepatitis B may be reactivated.
Long-term treatment with dexamethasone should only be established when strictly necessary and should be associated with specific treatment corresponding to each case.
In some cases, strict control of treatment by your doctor will be necessary. You should inform your doctor if you have any of the following symptoms:
Long-term treatment with this medicine requires periodic medical monitoring, including vision control every 3 months.
Contact your doctor if you experience blurred vision or other visual disturbances.
Signs of peritoneal irritation due to gastrointestinal perforation may not appear if you are taking high doses of this medicine.
If you take fluoroquinolones (substances with antibacterial activity) and corticosteroids (substances with anti-inflammatory properties), the risk of tendon disorders increases.
In cases of fever, accidents, operations, or childbirth, it may be necessary to temporarily increase the daily dose of this medicine.
Severe allergic reactions may occur.
Treatment with this medicine may worsen existing myasthenia gravis (a neuromuscular disease).
High doses of dexamethasone require adequate potassium supplements and sodium restrictions in the diet; and plasma potassium levels should be monitored.
Administration of high doses of dexamethasone may cause a slower heart rate.
Children and adolescents
Dexamethasone should not be used routinely in premature infants with respiratory problems.
Growth in children should be regularly monitored (see section 4).
Elderly patients
In elderly patients, the doctor should assess the benefits and risks of treatment.
Other medicines and Dexamethasone Novamis
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.
Some medicines may increase the effects of dexamethasone, so your doctor will perform thorough checks if you are taking these medicines (including some for HIV: ritonavir, cobicistat).
Taking dexamethasone with any of the following medicines may modify the effect of both dexamethasone and the medicine in question:
Interference with laboratory tests
Skin tests for allergy tests may give false results.
Do not stop taking any other steroid medication unless your doctor has indicated so.
Talk to your doctor, pharmacist, or nurse before administering this medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
This medicine is not recommended during pregnancy and breastfeeding, unless your doctor prescribes it. He will indicate whether you should stop breastfeeding or discontinue administration of this medicine.
Driving and using machines
No studies have been conducted on the ability to drive and use machines.
Use in athletes
Athletes are informed that this medicine contains a component that may produce a positive result in doping tests.
Dexamethasone Novamis contains lactose
This medicine contains lactose. If your doctor has indicated that you have an intolerance to certain sugars, consult with him before taking this medicine.
Follow your doctor's instructions for administering this medicine exactly. If in doubt, consult your doctor or pharmacist again.
The tablets are taken whole, during or after meals, with sufficient liquid. The tablet can be divided into equal doses.
Generally, the total daily dose will be taken in one intake, preferably in the morning, during or after breakfast, although it may be necessary to divide the dose into several intakes per day in patients who require high doses to achieve the maximum effect.
The treatment dose will depend on the type and severity of the disease and the individual patient's response. Your doctor will indicate the dose you should take, adjusting it to your needs, as well as the duration of treatment.
The dose should be high enough and the duration of treatment long enough, but on the other hand, the minimum effective dose should be maintained for the shortest possible time.
If you think the action of this medicine is too strong or too weak, inform your doctor or pharmacist.
For the treatment of Covid-19
In adult patients, it is recommended to take 6 mg orally once a day, up to a maximum of 10 days.
Use in adolescents
It is recommended to administer to pediatric patients (adolescents from 12 years of age) a dose of 6 mg orally once a day, up to a maximum of 10 days.
If you take more dexamethasone than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used. It is recommended to bring the package and the leaflet of the medicine to the healthcare professional.
Acute intoxications with dexamethasone are not known. In the event of an overdose, it is expected that the adverse reactions described in this leaflet will occur to a greater extent.
No antidote for dexamethasone is known.
If you forget to take dexamethasone
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is very close, skip the forgotten dose and take the next dose at its usual time.
If you interrupt treatment with dexamethasone
Do not stop treatment before your doctor indicates or abruptly, as it may worsen your disease.
Dose reduction should be done progressively. Similarly, treatment suspension should always be done progressively.
Excessive rapid reduction of the dose after long-term treatment may cause muscle and joint pain. Your doctor will gradually reduce the dose you should take.
If you interrupt long-term treatment, it may cause an increase in symptoms of your disease or a relapse, acute adrenocortical insufficiency (alteration of the production of certain hormones), and cortisone withdrawal syndrome characterized by general discomfort, weakness, and muscle pain, difficulty breathing, loss of appetite, nausea, vomiting, fever, decreased blood pressure, and blood sugar levels, among other symptoms.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
During the period of use of this medicine, the following side effects have been observed, whose frequency cannot be established with precision:
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es/. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the package after "EXP". The expiration date is the last day of the month indicated.
Store below 30°C. Store in the original packaging to protect it from moisture.
Medicines should not be disposed of through wastewater or household waste. Deposit the packages and medicines you no longer need in the SIGRE collection point at the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packages and medicines you no longer need. This way, you will help protect the environment.
Dexametasona Novamis Composition
Product Appearance and Packaging Contents
The dexamethasone 1 mg tablets are white, round, flat, and have beveled edges, with no coating. The tablet is engraved with a "D" and a "1" separated by a scored line on one side and is smooth on the other, with an approximate diameter of 9.2 mm. The tablet can be divided into equal doses.
The dexamethasone 1 mg tablets are available in boxes with PVC/PVdC/aluminum foil blisters containing 30 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Novamis Limited
Unit 1A, Block 1, Bracken Business Park
Bracken Road, Sandyford,
D18H283 Dublin,
Ireland
Manufacturer
SANTA S.A.
Panselelor str. no.25, no.27 and no.29,
Brasov Municipality, Brasov County, 500419
Romania
Date of the Last Revision of this Leaflet: August 2025
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)